Trademark Overview
On Wednesday, April 5, 2023, a trademark application was filed for BIOMARK with the United States Patent and Trademark Office. The USPTO has given the BIOMARK trademark a serial number of 97873713. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, June 11, 2024. This trademark is owned by BIOMARK CANCER SYSTEMS INC.. The BIOMARK trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Antibody reagents for in vitro diagnostic use for medical purposes; diagnostic kits consisting of monoclonal antibodies, buffers, and reagents for in vitro diagnostic use for medical purposes; medical diagnostic antibody reagents for use in medical imaging; diagnostic kits consisting of monoclonal antibodies, buffers and reagents for specialized medical Raman spectrometry to monitor toxicity of drugs for medical purposes, for use in disease testing, for testing of bodily fluids for use in disease detection, namely, cancer, for screening the acetylated form of Amantadine in body fluids and human tissues samples, for use in the early detection of cancer by detecting and analyzing the levels of Spermine/Spermidine N-Acetyl Transferase (SSAT) in human tissue samples; medical diagnostic assays for testing bodily fluids in drug screening applications, namely, assays for determining the efficacy of anti-cancer drugs; medical diagnostic assays for testing bodily fluids that test for the presen...
Medical testing of a biological sample taken from a patient for diagnostic purposes in the field of oncology; medical testing of a biological sample taken from a patient for medical screening purposes in the field of oncology; providing medical evaluation to assess and measure response to cancer treatment; medical analysis services relating to the treatment of cancer patients to help healthcare professionals determine the effectiveness of treatments and to revise future treatments; medical diagnostic testing, monitoring and reporting services relating to disease recurrence and progression in the field of oncology; providing medical support in the monitoring of patients receiving medical treatments, namely remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes, interactive medical monitoring and alert service for reminding clients of medical dosage, allergic sensitivity and prescription refill...
Providing an interactive web site featuring technology that enables users to enter, access, track, store, monitor, analyze and generate health and medical information and reports
